It promotes BC cell apoptosis by targeting JAK2 (Janus kinase 2) [30] and inhibits BC growth by targeting CXCR7 (CXC chemokine receptor 7) [28] and STMN1 (Stathmin1) [29]. Here, ACKR3 is linked to breast cancer.